WAM
ABMD

Wealthspire Advisors (Maryland)’s Abiomed Inc ABMD Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-429
Closed -$123K – 2258
2019
Q1 		$123K Buy
429
+4
+0.9% +$1.33K 0.01% 572
2018
Q4 		$138K Buy
425
+70
+20% +$24.3K 0.01% 509
2018
Q3 		$160K Sell
355
-4
-1% -$1.58K 0.01% 521
2018
Q2 		$147K Sell
359
-62
-15% -$22.5K 0.01% 563
2018
Q1 		$123K Sell
421
-70
-14% -$17.7K 0.01% 634
2017
Q4 		$92K Sell
491
-106
-18% -$19.8K 0.01% 745
2017
Q3 		$101K Sell
597
-2
-0.3% -$302 0.01% 704
2017
Q2 		$86K Hold
599
– – 0.01% 748
2017
Q1 		$75K Hold
599
– – 0.01% 683
2016
Q4 		$67K Buy
599
+239
+66% +$27.7K 0.01% 694
2016
Q3 		$46K Buy
360
+140
+64% +$16.8K 0.01% 803
2016
Q2 		$24K Buy
+220
New +$21.9K ﹤0.01% 948

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ABMD Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 429 shares — an estimated $123K sold.

Wealthspire Advisors (Maryland) first reported a position in ABMD in Q2 2016 and held it in 12 quarters. The position peaked at $160K in Q3 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 429 Abiomed Inc shares in Q2 2019, an estimated $123K.
  • Wealthspire Advisors (Maryland) first reported a position in Abiomed Inc in Q2 2016 and held it in 12 quarters.
  • Wealthspire Advisors (Maryland)'s Abiomed Inc position peaked at $160K in Q3 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.